0000899866-17-000008.txt : 20170109 0000899866-17-000008.hdr.sgml : 20170109 20170109172140 ACCESSION NUMBER: 0000899866-17-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170105 FILED AS OF DATE: 20170109 DATE AS OF CHANGE: 20170109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 2032722596 MAIL ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PARVEN ALVIN S CENTRAL INDEX KEY: 0001231950 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 17518626 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 4 1 wf-form4_148400047056942.xml FORM 4 X0306 4 2017-01-05 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231950 PARVEN ALVIN S C/O ALEXION PHARMACEUTICALS, INC 100 COLLEGE STREET NEW HAVEN CT 06510 1 0 0 0 Common Stock, par value $.0001 per share 2017-01-05 4 M 0 7932 26.64 A 14305 D Common Stock, par value $.0001 per share 2017-01-05 4 M 0 5572 49.43 A 19877 D Common Stock, par value $.0001 per share 2017-01-05 4 M 0 3237 85.75 A 23114 D Common Stock, par value $.0001 per share 2017-01-05 4 M 0 3425 96.35 A 26539 D Common Stock, par value $.0001 per share 2017-01-05 4 S 0 185 133.95 D 26354 D Common Stock, par value $.0001 per share 2017-01-05 4 S 0 369 135.70 D 25985 D Common Stock, par value $.0001 per share 2017-01-05 4 S 0 7375 137.56 D 18610 D Common Stock, par value $.0001 per share 2017-01-05 4 S 0 5176 138.60 D 13434 D Common Stock, par value $.0001 per share 2017-01-05 4 S 0 5350 139.49 D 8084 D Common Stock, par value $.0001 per share 2017-01-05 4 S 0 1433 140.59 D 6651 D Common Stock, par value $.0001 per share 2017-01-05 4 S 0 278 141.23 D 6373 D Common Stock, par value $.0001 per share 2017-01-05 4 S 0 853 133.65 D 5520 I by spouse's trust Common Stock, par value $.0001 per share 2017-01-05 4 S 0 15 133.95 D 5505 I by spouse Common Stock, par value $.0001 per share 2017-01-05 4 S 0 31 135.69 D 5474 I by spouse Common Stock, par value $.0001 per share 2017-01-05 4 S 0 599 137.56 D 4875 I by spouse Common Stock, par value $.0001 per share 2017-01-05 4 S 0 421 138.60 D 4454 I by spouse Common Stock, par value $.0001 per share 2017-01-05 4 S 0 435 139.49 D 4019 I by spouse Common Stock, par value $.0001 per share 2017-01-05 4 S 0 117 140.59 D 3902 I by spouse Common Stock, par value $.0001 per share 2017-01-05 4 S 0 22 141.22 D 3880 I by spouse Option to Purchase Common Stock 26.64 2017-01-05 4 M 0 7932 0 D 2010-08-12 2020-05-12 Common Stock, par value $.0001 per share 7932.0 0 D Option to Purchase Common Stock 49.43 2017-01-05 4 M 0 5572 0 D 2011-08-11 2021-05-11 Common Stock, par value $.0001 per share 0.0 0 D Option to Purchase Common Stock 85.75 2017-01-05 4 M 0 3237 0 D 2012-08-08 2022-05-08 Common Stock, par value $.0001 per share 3237.0 0 D Option to Purchase Common Stock 96.35 2017-01-05 4 M 0 3425 0 D 2013-08-07 2023-05-07 Common Stock, par value $.0001 per share 3425.0 0 D This transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $133.95 - $134.95. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $135.22 - $136.22. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $137.04 - $138.04. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $138.05 - $139.05. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $139.08 - $140.08. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $140.13 - $141.13. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $141.17 - $142.17. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $133.65 - $134.65. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. /s/ Michael Greco Attorney-in-Fact for Alvin Parven 2017-01-09